{
    "code": "52026602",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026602",
    "time": "2017-12-29 03:05:09",
    "許可證字號": "衛部藥輸字第026602號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/10\/20",
    "發證日期": "104\/10\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202660204",
    "中文品名": "&quot;康普萊&quot;膜衣錠",
    "英文品名": "Complera Film-coated Tablets",
    "適應症": "COMPLERA® (emtricitabine\/rilpivirine\/tenofovir disoproxil fumarate)是由兩種核苷類似物反轉錄酶抑制劑(NRTIs) (emtricitabine\/tenofovir DF)及一種非核苷反轉錄酶抑制劑 (NNRTI) (rilpivirine)組成之複方療法，適用於先前未曾使用過抗病毒藥物治療之愛滋病毒(HIV-1)感染之完整治療，且在治療開始時其病毒量HIV-1 RNA100,000 copies\/mL之12歲(含)以上患者；適用於特定正穩定接受抗反轉錄病毒療法，且治療開始時已達病毒學抑制狀態(HIV-1 RNA",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠塑膠瓶裝(HDPE)",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "TENOFOVIRDISOPROXILFUMARATE,EMTRICITABINE,RILPIVIRINEHYDROCHLORIDE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F070024200  PATHEON INC. - TORONTO REGION OPERATIONS",
        "製造廠廠址": "2100 SYNTEX COURT, MISSISSAUGA, ONTARIO, CANADA, L5N 7K9",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "F250332200  JANSSEN-CILAG SPA",
            "製造廠廠址": "VIA C. JANSSEN, B.GO SAN MICHELE, 04100 LATINA, ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": "包裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818003510",
            "成分名稱": "TENOFOVIR DISOPROXIL FUMARATE",
            "含量描述": "eq to 245mg tenofovir disoproxil",
            "含量": "300.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "0818003700",
            "成分名稱": "EMTRICITABINE",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "0818004310",
            "成分名稱": "RILPIVIRINE HYDROCHLORIDE",
            "含量描述": "eq to 25mg rilpivirine",
            "含量": "27.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "打樣版 PI_Complera_USPI Feb2016_v1701-106-07-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026602&Seq=004&Type=9"
        },
        {
            "title": "[打樣版] PI_Complera_USPI May2015_v1601-105-11-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026602&Seq=003&Type=9"
        },
        {
            "title": "Complera 瓶裝+尺規-105-11-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026602&Seq=011&Type=8"
        }
    ]
}